Clinical trial

Intelligent Digital Tools for Screening of Brain Connectivity and Dementia Risk Estimation in People Affected by Mild Cognitive Impairment

NCT05159661

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2021-03-01

PhaseN/A

Study timeline

Study start (actual)2021-03-01Date precision: day

Registry last updated2024-04-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cognitive Dysfunctionunresolved

Dementiaunresolved

Mild Cognitive Impairmentunresolved

Interventions

Sponsors & collaborators

Oslo University Hospitallead sponsor

Aalto Universitycollaborator

Accelopment AGcollaborator

Alzheimer Europecollaborator

BrainSymph AScollaborator

Det Norske Veritascollaborator

Helsinki University Central Hospitalcollaborator

IRCCS San Raffaele Romacollaborator

Lurtis Rules S.L.collaborator

Neuroconnect Srlcollaborator

Oslo Metropolitan Universitycollaborator

Radboud University Medical Centercollaborator

Tallinna Ülikoolcollaborator

Universidad Complutense de Madridcollaborator

Catholic University of the Sacred Heartcollaborator

Mapped research locations

RomaItaly2 MadridSpain1 OsloNorway1 HelsinkiFinland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05159661 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.